Medicare Part D and potentially inappropriate medication use in the elderly
- PMID: 23009330
- PMCID: PMC3622552
Medicare Part D and potentially inappropriate medication use in the elderly
Abstract
Objectives: Inappropriate medication use, which is common in older adults, may be responsive to out-of-pocket costs. We examined the impact of Medicare Part D on inappropriate medication use among Medicare beneficiaries.
Study design: Pre-post with comparison group.
Methods: Using data from 34,679 elderly beneficiaries in Medicare plans from 2004 to 2007, we used Healthcare Effectiveness Data and Information Set measures of prescribing quality: (1) any use of Drugs to Avoid in the Elderly (DAE), (2) a proportion of total medication use attributable to DAEs, and (3) any Potentially Harmful Drug-Disease Interactions in the Elderly (DDE). Rates of inappropriate use among 3 groups transitioning from no drug coverage or limited coverage ($150 or $350 quarterly caps) to Part D in 2006 were compared with those with constant drug coverage.
Results: DAE use increased slightly among those moving from no coverage to Part D (from 15.72%-17.61%) whereas the comparison group's use decreased (20.97%-18.32%) [relative odds ratio (ROR) = 1.34, 95% confidence interval [CI] 1.22-1.48, P <.0001]. However, the proportion of total drug use attributable to DAEs declined among the no coverage group after Part D (3.01%-1.98%), a significant difference relative to the comparison group (ROR = 0.84, 95% CI 0.72-0.98, P = .03). Rates of DDE were low (1%) both before and after Part D.
Conclusions: While use of high-risk drugs increased slightly among those gaining Part D drug coverage, high-risk drug use actually declined as a proportion of total drug use, and the prevalence of drug-disease interactions remained stable.
References
-
- Lindblad CI, Hanlon JT, Gross CR, et al. Clinically serious drug disease interactions in the elderly: opinion of a consensus panel. Clin Ther. 2006;28:1133–1143. - PubMed
-
- Stockl KM, Le L, Zhang S, Harada AS. Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. Am J Managed Care. 2010;16(1):e1–e10. - PubMed
-
- Kaiser Family Foundation . Fact Sheet: The Medicare Prescription Drug Benefit. Washington DC: 2008.
Publication types
MeSH terms
Grants and funding
- R01 AG034056/AG/NIA NIH HHS/United States
- 2R56AG027017/AG/NIA NIH HHS/United States
- 3U01 AG012553/AG/NIA NIH HHS/United States
- U01 AG012553/AG/NIA NIH HHS/United States
- R01AG034056/AG/NIA NIH HHS/United States
- R01 HS018721/HS/AHRQ HHS/United States
- R01 NR010135/NR/NINR NIH HHS/United States
- K07AG033174/AG/NIA NIH HHS/United States
- K07 AG033174/AG/NIA NIH HHS/United States
- P30 AG024827/AG/NIA NIH HHS/United States
- R01 AG027017/AG/NIA NIH HHS/United States
- R01 HS017695/HS/AHRQ HHS/United States
- KL2 RR024154/RR/NCRR NIH HHS/United States
- P30AG024827/AG/NIA NIH HHS/United States
- R34 MH082682/MH/NIMH NIH HHS/United States
- K12 HS019461/HS/AHRQ HHS/United States
- KL2 TR000146/TR/NCATS NIH HHS/United States
- T32 AG021885/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous